Community Health Systems Q4 EPS Tops Estimates While Revenue Drops 4.8%
Community Health Systems posted Q4 2025 revenue of $3.11 billion, a 4.78% year-over-year decline that missed estimates by $31.33 million, while GAAP EPS of $0.81 beat consensus by $0.83. RBC, Oppenheimer reiterated buy ratings at $5 and $4; management forecasts 2026 revenue of $11.6–12.0 billion and EBITDA of $1.34–1.49 billion.
1. Q4 2025 Financial Performance
Community Health Systems reported revenue of $3.11 billion for Q4 2025, a 4.78% year-over-year decline that fell short of estimates by $31.33 million. GAAP EPS was $0.81, surpassing consensus by $0.83, driven by cost controls and service mix improvements.
2. Operational Trends
Same-store revenue increased 2.1% year-over-year due to higher patient acuity, but same-store inpatient admissions and adjusted admissions each declined 0.3%. Surgical procedures fell 1.9% and emergency visits dropped 3.6%, reflecting broader utilization challenges.
3. Analyst Ratings and Price Targets
RBC and Oppenheimer reiterated buy ratings, assigning price targets of $5 and $4 respectively, signaling confidence in the company’s recovery plan. These calls follow management’s efforts to streamline operations and optimize capital allocation.
4. 2026 Financial Guidance
Management projects fiscal 2026 revenue between $11.6 billion and $12.0 billion, and adjusted EBITDA of $1.34 billion to $1.49 billion. The outlook incorporates planned efficiency initiatives and expectations for stable service volumes.